In Depth Research on Global Lung Cancer Vaccine Market & Pipeline Insight 2015

“Global Lung Cancer Vaccine Market & Pipeline Insight 2015” Report Highlights:

* Introduction to Lung Cancer Vaccine
* Global Lung Cancer Vaccine Market Analysis
* Global Lung Cancer Vaccine Pipeline by Company & Phase
* Global Lung Cancer Vaccine Pipeline: 29 Vaccines
* Majority Lung Cancer Vaccines in Phase-II: 8 Vaccines
* Marketed Lung Cancer Vaccines: 3 ( BV NSCLC 001, Mycidac-C™ & Vaxira®)
* Personalized Cancer Vaccines: Progress & Possibilities
* Lung Cancer Vaccine Mechanism

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:https://www.kuickresearch.com/report-Global-Lung-Cancer-Vaccine-Market-&-Pipeline-Insight-2015.php

Table of Contents

1. Introduction to Cancer Vaccines

2. Cancer Vaccines: Mechanism & Innovations
2.1 Idiotype Cancer Vaccine Mechanism
2.2 Cellular Cancer Vaccines Mechanism
2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
2.4 Peptide Cancer Vaccine Mechanism
2.5 Tumor Host Interaction Cancer Vaccine Mechanism

3. Introduction Global Lung Cancer Vaccine

4. Mechanism of Lung Cancer Vaccines

5. Global Lung Cancer Vaccine Market Outlook
5.1 Current Market Scenario
5.2 Global Lung Cancer Vaccines Pipeline Overview

6. Global Lung Cancer Market Dynamics
6.1 Favorable Market Parameters
6.2 Market & Commercialization Challenges

7. Global Lung Cancer Vaccine Market Future Prospects

8. Global Lung Cancer Vaccine Pipeline by Company & Phase
8.1 Preclinical
8.2 Clinical
8.3 Phase-I
8.4 Phase-I/II
8.5 Phase-II
8.6 Phase-II/III
8.7 Phase-III

9. Marketed Lung Cancer Vaccine Clinical Insight
9.1 BV NSCLC 001
9.2 Mycidac-C™
9.3 Vaxira®

10. Suspended & Discontinued Lung Cancer Vaccines Pipeline by Company & Phase
10.1 No Development Reported
10.2 Discontinued

11. Competitive Landscape
11.1 Boehringer Ingelheim
11.2 CureVac
11.3 Eli Lily
11.4 Galaxo
11.5 ImClone Systems
11.6 Merck
11.7 Ono Pharmaceutical
11.8 Oncothyreon Incorporation

Figure 1-1: Categorization & Function of Cancer Vaccines
Figure 2-1: Classification of Different Types of Cancer vaccines
Figure 3-1: Functions of Lungs
Figure 3-2: Factors Responsible for Increasing Lung Cancer Incidences
Figure 4-1: Type of Lung Cancer
Figure 4-2: Types of Lung Cancer Treatment
Figure 4-3: Mechanism of MAGE-3 Lung Cancer Vaccine
Figure 4-4: Mechanism of p53 Lung Cancer Vaccine
Figure 4-5: Mechanism of NY-ESO-1 Lung Cancer Vaccine
Figure 5-1: Global Lung Cancer Vaccines Pipeline (%), 2015
Figure 5-2: Global Lung Cancer Vaccines Pipeline (Number), 2015
Figure 5-3: No Development Reported in Lung Cancer Vaccines Pipeline (%), 2015
Figure 5-4: No Development Reported in Lung Cancer Vaccines Pipeline (Number), 2015
Figure 5-5: Discontinued Lung Cancer Vaccines Pipeline (%), 2015
Figure 5-6: Discontinued Lung Cancer Vaccines Pipeline (Number), 2015
Figure 6-1: Drivers for Lung Cancer Vaccines
Figure 6-2: Market & Commercialization Challenges

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
India
+91-11-47067990

This release was published on openPR.